324 related articles for article (PubMed ID: 6130430)
21. The relative potency of enkephalins and beta-endorphin in guinea-pig ileum, mouse vas deferens and rat vas deferens after the administration of peptidase inhibitors.
Kuno Y; Aoki K; Kajiwara M; Ishii K; Oka T
Jpn J Pharmacol; 1986 Jul; 41(3):273-81. PubMed ID: 3761746
[TBL] [Abstract][Full Text] [Related]
22. Rat vas deferens: a specific bioassay for endogenous opioid peptides.
Lemaire S; Magnan J; Regoli D
Br J Pharmacol; 1978 Nov; 64(3):327-9. PubMed ID: 719230
[TBL] [Abstract][Full Text] [Related]
23. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor.
Corbett AD; Gillan MG; Kosterlitz HW; McKnight AT; Paterson SJ; Robson LE
Br J Pharmacol; 1984 Sep; 83(1):271-9. PubMed ID: 6091824
[TBL] [Abstract][Full Text] [Related]
24. Human leumorphin is a potent, kappa opioid receptor agonist.
Suda M; Nakao K; Yoshimasa T; Sakamoto M; Morii N; Ikeda Y; Yanaihara C; Yanaihara N; Numa S; Imura H
Neurosci Lett; 1984 Sep; 50(1-3):49-52. PubMed ID: 6149506
[TBL] [Abstract][Full Text] [Related]
25. Dynorphin and neoendorphin peptides decrease dorsal root ganglion neuron calcium-dependent action potential duration.
Werz MA; Macdonald RL
J Pharmacol Exp Ther; 1985 Jul; 234(1):49-56. PubMed ID: 2409273
[TBL] [Abstract][Full Text] [Related]
26. Lack of evidence for epsilon-opioid receptors in the rat vas deferens.
Sheehan MJ; Hayes AG; Tyers MB
Eur J Pharmacol; 1988 Sep; 154(3):237-45. PubMed ID: 2853057
[TBL] [Abstract][Full Text] [Related]
27. The prenatal development profile of expression of opioid peptides and receptors in the mouse brain.
Rius RA; Barg J; Bem WT; Coscia CJ; Loh YP
Brain Res Dev Brain Res; 1991 Feb; 58(2):237-41. PubMed ID: 1674235
[TBL] [Abstract][Full Text] [Related]
28. Comparative study on the effect of morphine and the opioid-like peptides in the vas deferens of rodents: species and strain differences, evidence for multiple opiate receptors.
Huidobro-Toro JP; Way EL
Life Sci; 1981 Mar; 28(12):1331-6. PubMed ID: 6264244
[No Abstract] [Full Text] [Related]
29. Opioid profiles of Cys2-containing enkephalin analogues.
Pencheva N; Milanov P; Vezenkov L; Pajpanova T; Naydenova E
Eur J Pharmacol; 2004 Sep; 498(1-3):249-56. PubMed ID: 15364002
[TBL] [Abstract][Full Text] [Related]
30. Receptors for opioid peptides in the guinea-pig ileum.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1985 Nov; 235(2):389-92. PubMed ID: 2997432
[TBL] [Abstract][Full Text] [Related]
31. Characterization of kappa and delta opioid receptors in isolated organs by using type/subtype selective agonists and antagonists.
Makó E; Rónai AZ
Med Sci Monit; 2001; 7(3):350-6. PubMed ID: 11386008
[TBL] [Abstract][Full Text] [Related]
32. Generalization tests with intraventricularly applied pro-enkephalin B-derived peptides in rats trained to discriminate the opioid kappa receptor agonist ethylketocyclazocine.
Shearman GT; Schulz R; Schiller PW; Herz A
Psychopharmacology (Berl); 1985; 85(4):440-3. PubMed ID: 2862651
[TBL] [Abstract][Full Text] [Related]
33. Identification of opioid receptors on gastric muscle cells by selective receptor protection.
Grider JR; Makhlouf GM
Am J Physiol; 1991 Jan; 260(1 Pt 1):G103-7. PubMed ID: 1670978
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the opioid receptor type mediating inhibition of rat gastric somatostatin secretion.
McIntosh CH; Jia X; Kowk YN
Am J Physiol; 1990 Dec; 259(6 Pt 1):G922-7. PubMed ID: 1979718
[TBL] [Abstract][Full Text] [Related]
35. Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.
Vaught JL; Rothman RB; Westfall TC
Life Sci; 1982 Apr; 30(17):1443-55. PubMed ID: 6283293
[TBL] [Abstract][Full Text] [Related]
36. [Enkephalin-inactivating enzymes].
Oka T; Hiranuma T; Liu XF; Ohgiya N; Iwao K; Matsumiya T
Nihon Yakurigaku Zasshi; 1993 Apr; 101(4):197-207. PubMed ID: 8390390
[TBL] [Abstract][Full Text] [Related]
37. Met5-enkephalin-Arg6-Phe7 inhibition of noradrenaline and acetylcholine release from peripheral organs.
Hársing LG; Rónai AZ; Somogyi GT; Umezawa H; Bajusz S; Vizi ES
J Auton Pharmacol; 1984 Mar; 4(1):33-43. PubMed ID: 6325463
[TBL] [Abstract][Full Text] [Related]
38. Evidence for the epsilon-type of opioid receptor in the rat vas deferens.
Garzón J; Schulz R; Herz A
Mol Pharmacol; 1985 Jul; 28(1):1-9. PubMed ID: 2991732
[TBL] [Abstract][Full Text] [Related]
39. Opioid receptor selectivity of peptide models of beta-endorphin.
Taylor JW; Kaiser ET
Int J Pept Protein Res; 1989 Jul; 34(1):75-80. PubMed ID: 2551833
[TBL] [Abstract][Full Text] [Related]
40. [Leu5]enkephalin containing peptides derived from a common precursor: evaluation of opioid activity in in vitro bioassays.
Sanchez-Blazquez P; Garzon J; Lee NM
Eur J Pharmacol; 1984 Mar; 98(3-4):389-96. PubMed ID: 6327333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
